Clinical Trials Browser

Melanoma, Nevus, Skin Neoplasms

Skin Neoplasms

Uveal Melanoma, Melanoma

Uveal Melanoma, Melanoma

Melanoma, Neoplasms

Uveal Melanoma

Death, Melanoma, Neoplasm Metastasis, Recurrence

Skin Neoplasms

Uveal Melanoma

Kidney Neoplasms, Melanoma

Melanoma, Uveal Neoplasms

Melanoma, Sarcoma

Uveal Melanoma

Melanoma, Neoplasms

Uveal Melanoma, Melanoma

Agnosia, Skin Neoplasms

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Keratoacanthoma

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

Subcutaneous panniculitis-like T-cell lymphoma, Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Enteropathy-Associated T-Cell Lymphoma

Mucosal Melanoma

Pain, Keratosis, Actinic

Carcinoma, Basal Cell

Uveal Melanoma, Eye Neoplasms, Melanoma

Clinical Trials

MagMen-II

MEL

NEOPRIME

AI-DSSC

HAITILS

GoTIL-01

MK3475-C01

SCANDIUM II

WoW

ClearMark

SCANDIUM-III

Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer

L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma

NivoILP

ILP-NfL

SCANDIUM

ILP-Prime

SUMMIST

PEMDAC

LifeChamps Feasibility Study

An Exploratory Single-arm Study: PD-1 With Recombinant Human Adenovirus Type 5 Injection for Malignant Melanomas

HAITILS-PHP

Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Feasibility of Serratus Plane Block Associated With Sedation in Axillary Dissection

Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers

Sequentional Immuno Apheresis Plasma Volume Escalation Cohort Study of Reduction of Soluble Tumor Necrosis Factor Receptors 1 and 2 (sTNFR1/2) With or Without Nivolumab in Patients With Inoperable or Metastatic Solid Tumors

PAMela

CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL

Apatinib Plus SHR1210 in Advanced Mucosal Melanoma

Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy

Clinical Study of Apatinib as the Second-line Therapy in Malignant Melanoma

Pain Relief During Photodynamic Therapy for Actinic Keratoses With a New Irradiation Protocol

Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients

A Randomised Study Comparing Tissue Conservation in Conventional Versus Mohs' Surgery of Basal Cell Carcinoma

Pain Relief - Tramadol Versus Ibuprofen